Meet your #HRS2024 guides! This diverse group of HRS members will provide in-depth coverage & commentary before, during & after the meeting.

Follow them & #2024PaceSetter to track all the buzz & science from #Boston .

...and stay tuned for their top session picks!

#EPeeps …

Do all the recent advances in the treatment of #Afib make a measurable difference in society? Yep- ischemic stroke,
hemorrhagic stroke, and death
rates are all improving. Congrats Jean Jacques Noubiap academic.oup.com/ehjqcco/advanc… Prash Sanders European Society of Cardiology Journals
UCSF Cardiology Heart Rhythm Society

Solar Eclipse 2024 - a thread 🧵

1. Cleveland by Gabe Wasylko

Managing autonomic dysfunction in #CardOnc patients; slides by Dr. Olujimi Ajijola. #ACC24
🫀Screen for symptoms
🫀Test for autonomic neuropathy
🫀Identify exacerbating factors, and manage symptoms of those.

More on Bradycardia:
🫀In pts with myocarditis, treat it, and the Brady will usually resolve. Treat with steroids EARLY.
🫀Patients with prior chest radiation may be more likely to get PPMs for sick sinus syndrome.
#ACC24

Learning about Bradycardia in a cancer patient population. Key slides by Mike Fradley, MD (1/2)
🫀 Potentially offending therapies
#ACC24 #CardOnc

More AFib management in the cancer patient (2/2). #ACC24 #CardOnc
🫀Reasonable to choose DOACs over warfarin
🫀Mitigate bleeding risk by mgmt of HTN, other bleeding risk factors

How do we manage AFib in patients getting chemo? Key slides by Dr. Janice Chyou.
🫀Beware amio use with ibrutinib due to CYP3A4 inhibition
🫀QT prolongation can be exacerbated in setting of bradycardia
🫀Scant data on catheter ablation in the cancer patient
#ACC24

Ventricular Arrhythmias in the #CardOnc population by Edmond Cronin.
🫀Ibrutinib can induce VAs
🫀ICD therapy is as common in anthracycline-related cardiomyopathy as in DCM/ICM!
🫀Consider ICDs and CRT in those who would qualify by non-chemo related CM criteria
#ACC24

Thanks #ACC24 #ACC2024 for another 👏🏽 American College of Cardiology mtng❣️

Can’t emphasize enough my joy & pride in sharing these moments with Temple Cardiology Fellowship Temple IM Residency Temple Health Lewis Katz School of Medicine mentees, trainees, & colleagues🦉🥹 Martin G. Keane, MD

Honored to speak in #PAH and #CTEPH sessions

TACT2 Trial #LBCT #ACC24
🫀does chelation heals postMI patients with DM?
🫀27% 💃🏻 but diverse population
🫀68% complete all 40 infusion
🫀No difference in primary outcome of MI, stroke, 🏥, or revasc

⁉️differ from tact1: blood levels ⤵️ over time. Is this why?

This matters!!!! Joe Biden CMSGov U.S. FDA Dr. Robert M. Califf
Physicians are exhausted!!

Astonishing results from the DanGer Shock Trial presented at #ACC24 and out in NEJM today.

In patients with ST-elevation MI with cardiogenic shock, Impella reduced all-cause mortality (45.8% Impella vs. 58.5% control) at 180 days.

Some thoughts on this ground breaking trial:

1/
DanGer Shock Trial

“Impella might finally get to brag about a positive trial”!

nejm.org/doi/full/10.10…

Winners ! International Champions
American College of Cardiology #ACC24

Recognizing Dr Bill Van Decker as the best fellowship mentor and cards program director after 20 years of being their fellows at ACC 2024 ——what a joy ⁦Jennifer Ting⁩ ⁦Amit R. Patel⁩ ⁦Ijeoma Isiadinso MD MPH FACC FASNC⁩ ⁦Mohamad Alkhouli⁩ ⁦Temple Cardiology Fellowship⁩

I've always felt like chelation therapy was voodoo.
The first bar for any hypothesis is biological plausibility.
Let's see this weekend...

Al-Shifa hospital in #Gaza this morning, following the end of the latest Israeli siege.

I repeat: hospitals must be respected and protected; they must not be used as battlefields.